1. Introduction {#sec1-medicina-54-00091}
===============

Age-related changes in body composition, characterized by a decrease in bone mineral density and muscle mass and an increment of fat mass, is a concern in the aged society \[[@B1-medicina-54-00091]\]. Sarcopenia, obesity and osteopenia/osteoporosis are three frequent chronic diseases in the older population but these conditions are progressive and initiate at a younger age \[[@B2-medicina-54-00091],[@B3-medicina-54-00091]\]. These body composition changes are related to a decrease in the quality of life and an increase of mortality risk \[[@B4-medicina-54-00091]\], producing a significant burden on individual wellness and public health \[[@B3-medicina-54-00091]\].

Another significant concern associated with ageing is sleep pattern changes \[[@B5-medicina-54-00091]\], including a decrease in the quantity and quality of sleep \[[@B5-medicina-54-00091]\]. It has been estimated that approximately 50% of older adults complain about difficulty initiating or maintaining sleep \[[@B6-medicina-54-00091]\]. A poor sleep quality could increase inflammation, decrease melatonin production and disrupt the circadian rhythms \[[@B7-medicina-54-00091]\], which are involved in several diseases related to the ageing process, such as, coronary heart disease \[[@B8-medicina-54-00091]\], type 2 diabetes \[[@B9-medicina-54-00091]\], obesity \[[@B10-medicina-54-00091]\], depression \[[@B11-medicina-54-00091]\], and consequently an increased risk of mortality \[[@B6-medicina-54-00091]\].

Certain studies have proposed a relationship between sleep quality and bone mineral density \[[@B12-medicina-54-00091]\], muscle mass \[[@B13-medicina-54-00091]\] and fat mass \[[@B14-medicina-54-00091]\]. A poor sleep quality deregulates the catabolic/anabolic cycle increasing the risk of osteoporosis \[[@B15-medicina-54-00091]\], induces high insulin resistance increasing the risk of sarcopenia \[[@B16-medicina-54-00091]\], and produces metabolic and endocrine alterations increasing the risk of obesity \[[@B17-medicina-54-00091]\]. However, these studies used subjective questionnaires to assess sleep quality. Although these questionnaires have been previously validated, there are no studies that evaluate the association between sleep quality measured by accelerometry with body composition parameters.

This study aimed to analyse the association between sleep quality (measured using subjective and objective methods) with an extensive set of body composition parameters (waist-hip ratio, body mass index, bone mineral content, bone mineral density, lean mass, lean mass index, fat mass, fat mass percentage, fat mass index, visceral adipose tissue) in sedentary middle-aged adults. We also aimed to evaluate whether these associations were similar considering sleep quality measured by subjective versus objective methods. We hypothesized that participants with poor sleep quality would have low bone mineral density, low lean mass and high fat mass levels. Additionally, we hypothesized that these associations would be similar in subjective and objective methods.

2. Materials and Methods {#sec2-medicina-54-00091}
========================

2.1. Participants {#sec2dot1-medicina-54-00091}
-----------------

A total of 74 (39 women) middle-aged sedentary adults (40--65 years old) took part in the present study. The participants were enrolled in the FIT-AGEING study \[[@B18-medicina-54-00091]\], an exercise-based randomized controlled trial ([clinicaltrial.gov](clinicaltrial.gov): ID: NCT03334357). All participants reported to be non-physically active (\<20 min of moderate-intensity physical activity on 3 days/week), with stable weight (weight changes \<5 kg) over the last 5 months, free of disease, and not taking any medication. The study was approved by the Ethics Committee on Human Research at the University of Granada and Servicio Andaluz de Salud (CEI-Granada) (0838-N-2017) (25 September 2017). The study protocols and experimental design were applied in accordance with the last revised ethical guidelines of the Declaration of Helsinki. All participants signed an informed consent. All variables were assessed at the baseline of the FIT-AGEING study \[[@B18-medicina-54-00091]\].

2.2. Sleep Quality Assessment {#sec2dot2-medicina-54-00091}
-----------------------------

The sleep quality of the participants was assessed by the Pittsburgh sleep quality index (PSQI) scale, a 19-item scale that provides 7 component scores (ranges 0--3) \[[@B19-medicina-54-00091]\]. It consists of 7 elements: (i) subjective sleep quality (very good to very bad), (ii) sleep latency (≤15 min to \>60 min), (iii) sleep duration (≥7 h to \<5 h), (iv) sleep efficiency (≥85% to \<65% hours sleep/hours in bed), (v) sleep disturbances (not during the past month to ≥ 3 times per week), (vi) use of sleeping medications (none to ≥ 3 times a week), and (vii) daytime dysfunction (not a problem to a very big problem); with a total global score ranging from 0 to 21 \[[@B19-medicina-54-00091]\]. A PSQI global score more than 5 was considered as poor sleep quality \[[@B19-medicina-54-00091]\].

Objective characteristics of sleep-wake patterns were measured with a wrist-worn accelerometer (ActiSleep, ActiGraph, Pensacola, FL, USA) for 7 consecutive days (24 h/day) \[[@B18-medicina-54-00091]\]. The participants received detailed information on how to wear the accelerometer and were asked to remove it only during water activities. They also recorded the times they went to bed each night, woke up each morning and removed the device every day. Data were processed using the ActiLife v. 6.13.3 software (ActiGraph, Pensacola, FL, USA). The accelerometers were initialized to store raw accelerations at a sampling frequency of 100 Hz \[[@B20-medicina-54-00091]\]. The following variables were analyzed: Total sleep time (minutes slept between bedtime and wake time), sleep efficiency (percentage of time asleep while in bed) and wake after sleep onset (minutes awake between sleep onset and wake time). Wake after sleep onset referred to periods of wakefulness occurring after defined sleep onset, and it was a measurement of wakefulness, reflecting sleep fragmentation \[[@B21-medicina-54-00091]\].

2.3. Anthropometric and Body Composition Assessment {#sec2dot3-medicina-54-00091}
---------------------------------------------------

Body weight and height measurements were performed without shoes and with light clothing, using a pre-validated scale and stadiometer (model 799, Electronic Column Scale, Hamburg, Germany) and the body mass index (BMI) was calculated (weight/height^2^) \[[@B22-medicina-54-00091]\].

We measured (in triplicate) waist circumference (WC) at the midpoint between the lowest rib cage and the top of the iliac crest and hip circumference (HC) around the widest portion of the buttocks with a non-elastic tape (Seca 200, MWS Ltd., Scalesmart, Leicester, UK) to the nearest 0.1 cm. Waist-hip ratio (WHiR) was calculated by dividing waist measurement by hip measurement.

A dual-energy X-ray absorptiometry scanner (Discovery Wi, Hologic, Inc., Bedford, MA, USA) was used to measure body composition following the manufacturer's recommendations. The whole-body scan was considered to obtain all body composition parameters (bone mineral content, lean mass, fat mass and visceral adipose tissue). We conducted the quality controls, the positioning of the participants, and the analyses of the results following the manufacturer's recommendations. An automatic delineation of the anatomic regions was performed by the software APEX 4.0.2. We acquired spine phantom quality control scans on each study day. Bone mineral density (BMD) was calculated as bone mineral content (BMC) in g divided by the total bone surface in cm^2^. Lean mass index (LMI) was calculated as lean mass in kg divided by height in m^2^. Similarly, we calculated the fat mass index (FMI) as fat mass in kg divided by height in m^2^. Fat mass was also expressed as weight percentage.

2.4. Statistical Analysis {#sec2dot4-medicina-54-00091}
-------------------------

The sample size and power calculations were made based on the data of a pilot study \[[@B18-medicina-54-00091]\]. The Shapiro--Wilk test, visual check of histograms, Q-Q and box plots were used to verify the distribution of all variables. The descriptive parameters were reported as mean and standard deviation.

We conducted simple linear regression models to examine the association of sleep quality (PSQI global score, total sleep time, sleep efficiency and wake after sleep onset) with body composition parameters (BMI, WHiR, BMC, BMD, lean mass, LMI, fat mass, fat mass percentage, FMI, and visceral adipose tissue).

We also conducted multiple linear regression models to test these associations after adjusting by sex, and age.

All analyses were conducted using the Statistical Package for Social Sciences (SPSS, v. 25.0, IBM SPSS Statistics, IBM Corporation) and the level of significance was set at \<0.05. Graphical presentations were prepared using GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA).

3. Results {#sec3-medicina-54-00091}
==========

The characteristics of the study sample are shown in [Table 1](#medicina-54-00091-t001){ref-type="table"}.

The PSQI global score was negatively associated with the BMI (β = −0.274, R^2^ = 0.072, *p* = 0.028; [Figure 1](#medicina-54-00091-f001){ref-type="fig"}A), which disappeared after including sex, and both sex and age in the model (all *p* \> 0.05; [Table 2](#medicina-54-00091-t002){ref-type="table"}). The PSQI global score was not associated with the WHiR (β = −0.003, R^2^ = 0.017, *p* = 0.293; [Figure 1](#medicina-54-00091-f001){ref-type="fig"}E) neither after including sex, age, and both sex and age in the model (all *p* \> 0.05; [Table 2](#medicina-54-00091-t002){ref-type="table"}).

No association was found between total sleep time and BMI (β = −0.018, R^2^ = 0.054, *p* = 0.051; [Figure 1](#medicina-54-00091-f001){ref-type="fig"}B), neither including sex or both sex and age in the model (all *p* \> 0.05; [Table 3](#medicina-54-00091-t003){ref-type="table"}) and was negatively associated when we included age (β = −0.019, R^2^ = 0.083, *p* = 0.040; [Table 3](#medicina-54-00091-t003){ref-type="table"}) in the model. Total sleep time was negatively associated with WHiR (β=−0.001, R^2^ = 0.111, *p* = 0.004; [Figure 1](#medicina-54-00091-f001){ref-type="fig"}F), which disappeared after including sex or both sex and age in the model (all *p* \> 0.05; [Table 3](#medicina-54-00091-t003){ref-type="table"}) and remained after including age in the model (β = −0.001, R^2^ = 0.126, *p* = 0.006; [Table 3](#medicina-54-00091-t003){ref-type="table"}).

No association was found between sleep efficiency and the wake after sleep onset with BMI and WHiR (all *p* \> 0.05; [Figure 1](#medicina-54-00091-f001){ref-type="fig"}C,D, respectively for BMI and [Figure 1](#medicina-54-00091-f001){ref-type="fig"}G,H, respectively for WHiR), neither after including sex age or both sex and age in the model (all *p* \> 0.05; [Table 4](#medicina-54-00091-t004){ref-type="table"} and [Table 5](#medicina-54-00091-t005){ref-type="table"}).

The PSQI global score was negatively associated with the BMC and the BMD (β = −42.411, R^2^ = 0.107, *p* = 0.007; [Figure 2](#medicina-54-00091-f002){ref-type="fig"}A; β = −0.013, R^2^ = 0.197, *p* \< 0.001; [Figure 2](#medicina-54-00091-f002){ref-type="fig"}E respectively), which remained after including sex (β = −20.624, R^2^ = 0.634, *p* = 0.045; β = −0.010, R^2^ = 0.419, *p* = 0.001 respectively; [Table 2](#medicina-54-00091-t002){ref-type="table"}) and age (β = −42.544, R^2^ = 0.107, *p* = 0.009; β = −0.013, R^2^ = 0.197, *p* \< 0.001 respectively; [Table 2](#medicina-54-00091-t002){ref-type="table"}) in the model. However, when we included both sex and age in the model, the association between the PSQI global score and BMC disappeared (*p* \> 0.05; [Table 2](#medicina-54-00091-t002){ref-type="table"}), and remained with BMD (β = −14.293, R^2^ = 0.230, *p* = 0.003; [Table 2](#medicina-54-00091-t002){ref-type="table"}).

The total sleep time was negatively associated with the BMC and the BMD (β = −3.622, R^2^ = 0.148, *p* = 0.001; [Figure 2](#medicina-54-00091-f002){ref-type="fig"}B; β = −0.001, R^2^ = 0.150, *p* = 0.001; [Figure 2](#medicina-54-00091-f002){ref-type="fig"}F respectively), which disappeared after including sex in the model or both sex and age in the model (all *p* \> 0.05; [Table 3](#medicina-54-00091-t003){ref-type="table"}) and remained after including age in the model (β = −3.664, R^2^ = 0.152, *p* = 0.001; β = −0.001; R^2^ = 0.159, *p* = 0.001 respectively; [Table 3](#medicina-54-00091-t003){ref-type="table"}).

No association was found between the sleep efficiency and the wake after sleep onset with the BMC and the BMD (all *p* \> 0.05; [Figure 2](#medicina-54-00091-f002){ref-type="fig"}C,D, respectively for BMC and [Figure 2](#medicina-54-00091-f002){ref-type="fig"}G,H, respectively for BMD), neither after including sex, age or both sex and age in the model (all *p* \> 0.05; [Table 5](#medicina-54-00091-t005){ref-type="table"}).

The PSQI global score was negatively associated with the lean mass and the LMI (β = −1.081, R^2^ = 0.103, *p* = 0.008; [Figure 3](#medicina-54-00091-f003){ref-type="fig"}A; β = −0.367, R^2^ = 0.193, *p* \< 0.001; [Figure 3](#medicina-54-00091-f003){ref-type="fig"}E respectively), which remained after including sex (β = −0.466, R^2^ = 0.725, *p* = 0.044; β = −0.238, R^2^ = 0.640, *p* \< 0.001 respectively; [Table 2](#medicina-54-00091-t002){ref-type="table"}) and age (β = −1.001, R^2^ = 0.115, *p* = 0.016; β = −0.332, R^2^ = 0.228, *p* = 0.001 respectively; [Table 2](#medicina-54-00091-t002){ref-type="table"}) in the model. However, when we included both sex and age in the model, the association between the PSQI global score and lean mass disappeared (*p* \> 0.05; [Table 2](#medicina-54-00091-t002){ref-type="table"}), and remained with LMI (β = −0.724, R^2^ = 0.219, *p* = 0.004; [Table 2](#medicina-54-00091-t002){ref-type="table"}).

No association was found between the sleep efficiency and the wake after sleep onset with the lean mass and the LMI (all *p* \> 0.05; [Figure 3](#medicina-54-00091-f003){ref-type="fig"}C,D respectively for lean mass [Figure 3](#medicina-54-00091-f003){ref-type="fig"}G,H respectively for LMI), neither when we included sex, age or both sex and age in the model (all *p* \> 0.05; [Table 4](#medicina-54-00091-t004){ref-type="table"} and [Table 5](#medicina-54-00091-t005){ref-type="table"}).

The PSQI global score and the total sleep time were positively associated with the fat mass percentage (β = 0.809, R^2^ = 0.100, *p* = 0.009; [Figure 4](#medicina-54-00091-f004){ref-type="fig"}A; β = 0.047, R^2^ = 0.065, *p* = 0.033; [Figure 4](#medicina-54-00091-f004){ref-type="fig"}B, respectively), which disappeared after including sex or both sex and age in the model (all *p* \> 0.05; [Table 2](#medicina-54-00091-t002){ref-type="table"} and [Table 3](#medicina-54-00091-t003){ref-type="table"}) and remained after including age in the model (β = 0.765, R^2^ = 0.106, *p* = 0.016; [Table 2](#medicina-54-00091-t002){ref-type="table"}; β = 0.049, R^2^ = 0.109, *p* = 0.022; [Table 3](#medicina-54-00091-t003){ref-type="table"} respectively).

No association was found between the PSQI global score and the total sleep with the FMI (all *p* \> 0.05; [Figure 4](#medicina-54-00091-f004){ref-type="fig"}E,F, respectively), neither after including sex, age or both sex and age in the model (all *p* \> 0.05; [Table 2](#medicina-54-00091-t002){ref-type="table"} and [Table 3](#medicina-54-00091-t003){ref-type="table"}, respectively).

No association was found between the sleep efficiency and the wake after sleep onset with the fat mass percentage and the FMI (all *p* \> 0.05; [Figure 4](#medicina-54-00091-f004){ref-type="fig"}C,D respectively for fat mass percentage and [Figure 4](#medicina-54-00091-f004){ref-type="fig"}G and 4H respectively for FMI), neither when we included sex, age or both sex and age in the model (all *p* \> 0.05; [Table 4](#medicina-54-00091-t004){ref-type="table"} and [Table 5](#medicina-54-00091-t005){ref-type="table"}).

4. Discussion {#sec4-medicina-54-00091}
=============

The present study showed that a poor subjective sleep quality was negatively associated with BMC, BMD, lean mass and LMI, and positively associated with the fat mass percentage in middle-aged adults. However, no association was found between objective sleep quality and any body composition variable, neither when we accounted for sex and age.

Osteoporosis is a prevalent age-related disease characterized by low bone mass and microarchitectural deterioration of bone tissue \[[@B15-medicina-54-00091]\], and a poor sleep quality could be a risk factor for osteoporosis and osteopenia in middle-aged adults \[[@B23-medicina-54-00091]\]. A poor sleep quality could have different physiological effects that negatively influence the BMD: (i) Alteration of circadian rhythms that disrupt bone microstructure \[[@B24-medicina-54-00091]\]; (ii) an elevation of pro-inflammatory cytokines \[[@B25-medicina-54-00091]\], which are linked to osteoporosis \[[@B26-medicina-54-00091]\]; (iii) an abnormal melatonin secretion \[[@B27-medicina-54-00091]\], since low melatonin levels are related to bone disease and abnormality \[[@B28-medicina-54-00091]\]; (iv) an elevation of cortisol \[[@B25-medicina-54-00091]\], since cortisol hypersecretion decreases bone cell growth and decreases BMD \[[@B29-medicina-54-00091]\]; (v) decreased levels of leptin \[[@B25-medicina-54-00091]\], which adequate levels have been positively correlated with BMD \[[@B30-medicina-54-00091]\]. All aforementioned mechanisms could negatively influence BMD increasing the risk of developing osteoporosis. Our results agree with others studies that demonstrated that poor sleep quality could be associated with low BMD in middle-aged women \[[@B12-medicina-54-00091]\], in young men \[[@B31-medicina-54-00091]\], and older adults \[[@B32-medicina-54-00091]\].

Sarcopenia is the continuous and progressive age-related decline in skeletal muscle mass \[[@B16-medicina-54-00091]\]. A poor quality of sleep has been demonstrated to be a risk factor for age-related sarcopenia \[[@B16-medicina-54-00091]\]. There are several mechanisms that could explain the negative influence of poor sleep quality on lean mass: (i) An increment in the secretion of the catabolic hormone cortisol \[[@B33-medicina-54-00091]\], which is known to stimulate degradation and inhibit synthesis of muscle proteins \[[@B34-medicina-54-00091]\]; (ii) a disruption of the physiological rhythm of the anabolic hormone testosterone; (iii) an alteration of the secretion peak of the anabolic hormone growth hormone \[[@B25-medicina-54-00091]\]; (iv) a decrease in insulin growth factor 1 (IGF-1) concentration \[[@B35-medicina-54-00091]\], which has a key role in the stimulation of muscle protein synthesis \[[@B36-medicina-54-00091]\]; (v) an increment of pro-inflammatory cytokines \[[@B25-medicina-54-00091]\], which are related to muscle atrophy \[[@B36-medicina-54-00091]\]; and (vi) an increase on insulin resistance \[[@B37-medicina-54-00091]\], which may limit the muscle protein synthesis \[[@B38-medicina-54-00091]\]. In relation to lean mass, our results agreed with those obtained by a cross-sectional study that included 1,196 elderly participants \[[@B13-medicina-54-00091]\].

Obesity is characterized by an excessive accumulation of adiposity, which is highly prevalent during the ageing process \[[@B39-medicina-54-00091]\]. A poor sleep quality increases inflammation \[[@B25-medicina-54-00091]\], which is significantly elevated in obesity \[[@B40-medicina-54-00091]\]. Additionally, poor sleep quality alters circadian rhythms increasing fatness through different mechanisms (i.e., dietary habits disruption, hormonal disruption, etc.) \[[@B41-medicina-54-00091]\]. A poor sleep quality can disturb melatonin secretion \[[@B27-medicina-54-00091]\], which has demonstrated to be the key mediator for the optimization of energy balance and body weight regulation \[[@B42-medicina-54-00091]\], with a direct relationship with fatness and obesity \[[@B42-medicina-54-00091]\]. Poor sleep quality is associated with low leptin and high ghrelin, which are likely to increase appetite, and consequently the risk of obesity \[[@B25-medicina-54-00091]\]. It has been reported that low sleep quality decreases adiponectin levels \[[@B43-medicina-54-00091]\], which is inversely correlated with adiposity \[[@B44-medicina-54-00091]\]. Healthy individuals with poor sleep quality are more insulin resistant \[[@B37-medicina-54-00091]\], which is associated with an increment in adiposity \[[@B45-medicina-54-00091]\]. A poor sleep quality through all aforementioned mechanisms could increase adiposity, and consequently, increase the risk of developing obesity. In line with our results, previous studies reported a relationship between poor sleep quality and higher fat mass in middle-aged adults \[[@B46-medicina-54-00091]\], young adolescents \[[@B47-medicina-54-00091]\] and college students \[[@B14-medicina-54-00091]\].

The lack of association between sleep parameters and body composition parameters when sex or age were accounted for, could be explain by: (i) The sex differences in sleep and sleep disorders between women and men \[[@B48-medicina-54-00091]\], which could be based on differences in physiological conditions between sexes like menstrual cycles, male and female hormones \[[@B49-medicina-54-00091]\] and differences in circadian rhythms \[[@B50-medicina-54-00091]\] and (ii) the age-related sleep changes, and the common sleep disturbances that arise with advancing age \[[@B6-medicina-54-00091]\].

Interestingly, we observed different results when the association between sleep quality and body composition was performed considering subjective sleep quality measured by a PSQI questionnaire versus objective sleep quality measured with an accelerometer. A previous study in youth observed that the PSQI and the accelerometer may measure different attributes of sleep, reporting the inadequate capacity of an accelerometry to detect wakefulness, thus lying in bed awake but motionless is likely to be coded as sleep \[[@B51-medicina-54-00091]\]. Due to this limitation, using both complementary assessment methods (objective and subjective) to obtain detailed information beyond the limited data derived from body movements, is recommended \[[@B52-medicina-54-00091]\].

This study has some limitations that have to be considered: Firstly, we cannot clarify by this cross-sectional study whether sleep quality contributes to maintenance adequate body composition variables (i.e., high BMD, low fat mass, and high lean mass), or whether the body composition status has a positive influence on sleep quality. Longitudinal studies are needed to clarify the direction of the association. Secondly, our study only included middle-aged sedentary adults, thus we cannot extrapolate our results to older, younger, and/or physically active individuals. Thirdly, the sample size of this study was relatively small. Finally, the lack of blood parameters mentioned above, does not allow for confirmation that the relationship is due to the proposed physiological mechanisms. Despite the aforementioned limitations, we measured sleep quality subjectively and objectively, which was indeed the strength of this study, since prior similar studies did not objectively measure sleep quality \[[@B12-medicina-54-00091],[@B13-medicina-54-00091],[@B14-medicina-54-00091],[@B31-medicina-54-00091],[@B32-medicina-54-00091],[@B46-medicina-54-00091]\].

5. Conclusions {#sec5-medicina-54-00091}
==============

In conclusion, our study showed that a subjective poor sleep quality was negatively associated with BMC, BMD, lean mass and LMI whereas was positively associated with fat mass percentage in middle-aged adults. Interestingly, we observed different results when the association between sleep quality and body composition was performed considering subjective sleep quality measured by a PSQI questionnaire versus objective sleep quality measured with an accelerometer. Nevertheless, further studies are needed to confirm the observed association in individuals with similar and different characteristics since the sample size of this study was relatively small. Longitudinal studies are also required to establish the causal association between body composition variables and sleep quality.
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medicina-54-00091-t001_Table 1

###### 

Descriptive parameters.

                                    All (*n* = 74)   Men (*n* = 35)   Women (*n* = 39)
  --------------------------------- ---------------- ---------------- ------------------
  Age (years)                       53.7 ± 5.1       54.4 ± 5.3       53.0 ± 5.0
  **Body composition parameters**                                     
  Body mass index (kg/m^2^)         26.7 ± 3.8       28.3 ± 3.6       25.3 ± 3.3
  Waist-Hip ratio                   0.91 ± 0.08      0.97 ± 0.07      0.86 ± 0.06
  Bone mineral content (g)          2258.1 ± 453.5   2633.6 ± 301.2   1921.1 ± 259.8
  Bone mineral density (g/cm^2^)    1.10 ± 0.10      1.16 ± 0.08      1.05 ± 0.09
  Lean mass (kg)                    43.5 ± 11.7      53.9 ± 6.5       34.1 ± 5.8
  Lean mass index (kg/m^2^)         15.2 ± 2.9       17.5 ± 2.0       13.2 ± 1.8
  Fat mass (kg)                     30.0 ± 8.4       30.9 ± 9.8       29.2 ± 7.1
  Fat mass (%)                      39.9 ± 9.1       34.7 ± 8.0       44.5 ± 7.4
  Fat mass index (kg/m^2^)          10.7 ± 3.1       10.0 ± 3.2       11.4 ± 2.9
  **Sleep quality parameters**                                        
  PSQI global score                 5.6 ± 3.5        4.8 ± 3.1        6.3 ± 3.6
  Total sleep time (min)            359.9 ± 48.8     337.9 ± 46.3     380.1 ± 42.4
  Sleep efficiency (%)              85.0 ± 6.3       84.9 ± 7.5       86.1 ± 4.7
  Wake after sleep onset (min)      63.9 ± 27.4      65.8 ± 32.4      62.2 ± 22.2

Values are expressed as mean ± standard deviation. Abbreviations: PSQI---Pittsburgh sleep quality index.

medicina-54-00091-t002_Table 2

###### 

Association of PSQI global score with body composition parameters.

                                   All (*n* = 74)                                                                           
  -------------------------------- ---------------- ------- ------------- --------- ------- ------------- --------- ------- -----------
  Body mass index (kg/m^2^)        −0.188           0.204   0.112         −0.241    0.094   0.057         −0.144    0.127   0.279
  Waist-Hip ratio                  −5.498           0.345   0.982         −0.004    0.050   0.178         −1.030    0.111   0.867
  Bone mineral content (g)         −20.624          0.634   **0.045**     −42.544   0.107   **0.009**     −0.002    0.144   0.121
  Bone mineral density (g/cm^2^)   −0.010           0.419   **0.001**     −0.013    0.197   **\<0.001**   −14.293   0.230   **0.003**
  Lean mass (kg)                   −0.466           0.725   **0.044**     −1.001    0.115   **0.016**     −8.629    0.129   0.259
  Lean mass index (kg/m^2^)        −0.238           0.640   **\<0.001**   −0.332    0.228   **0.001**     −0.724    0.219   **0.004**
  Fat mass (kg)                    0.331            0.026   0.255         0.274     0.014   0.346         5.945     0.129   0.256
  Fat mass (%)                     0.511            0.353   0.058         0.765     0.106   **0.016**     0.083     0.140   0.150
  Fat mass index (kg/m^2^)         0.072            0.068   0.506         0.116     0.018   0.297         0.077     0.115   0.588
  Visceral adipose tissue (g)      6.407            0.188   0.591         −5.293    0.006   0.687         0.001     0.115   0.583

The analyses were controlled for: Sex (Model 1); age (Model 2); both sex and age (Model 3). β---unstandardized regression coefficient; R^2^, and *p* value were obtained from the multiple linear regression analyses. Abbreviations: PSQI---Pittsburgh sleep quality index; bold values are values that are significant (*p* \< 0.05).

medicina-54-00091-t003_Table 3

###### 

Association of sleep time with body composition parameters.

                                   All (*n* = 74)                                                                     
  -------------------------------- ---------------- ------- ------- -------- ------- ------------- ---------- ------- -------
  Body mass index (kg/m^2^)        −0.005           0.182   0.622   −0.019   0.083   **0.040**     −0.876     0.192   0.587
  Waist-Hip ratio                  0.000            0.391   0.455   −0.001   0.126   **0.006**     −58.250    0.195   0.467
  Bone mineral content (g)         −0.441           0.639   0.565   −3.664   0.152   **0.001**     −0.012     0.193   0.532
  Bone mineral density (g/cm^2^)   0.000            0.352   0.120   −0.001   0.159   **0.001**     −102.173   0.219   0.110
  Lean mass (kg)                   −0.004           0.734   0.825   −0.096   0.186   **0.001**     0.000      0.190   0.718
  Lean mass index (kg/m^2^)        −0.003           0.563   0.544   −0.023   0.237   **\<0.001**   −2.916     0.198   0.393
  Fat mass (kg)                    0.007            0.019   0.775   −0.003   0.010   0.870         0.000      0.190   0.765
  Fat mass (%)                     0.006            0.275   0.774   0.049    0.109   **0.022**     0.261      0.190   0.724
  Fat mass index (kg/m^2^)         −7.391           0.039   0.993   0.006    0.016   0.451         0.020      0.189   0.991
  Visceral adipose tissue (g)      −0.576           0.221   0.548   −2.049   0.073   **0.033**     −0.009     0.193   0.555

The analyses were controlled for: Sex (Model 1); age (Model 2); both sex and age (Model 3). β---unstandardized regression coefficient; R^2^, and *p* value were obtained from the multiple linear regression analyses. Bold values are values that are significant (*p* \< 0.05).

medicina-54-00091-t004_Table 4

###### 

Association of sleep efficiency with body composition parameters.

                                   All (*n* = 74)                                                               
  -------------------------------- ---------------- ------- ------- ---------- ------- ------- -------- ------- -------
  Body mass index (kg/m^2^)        3.686            0.183   0.584   −1.190     0.024   0.869   0.120    0.035   0.598
  Waist-Hip ratio                  0.020            0.386   0.879   −0.122     0.028   0.460   1.861    0.031   0.869
  Bone mineral content (g)         71.598           0.637   0.896   −960.826   0.019   0.279   0.000    0.031   0.918
  Bone mineral density (g/cm^2^)   −0.101           0.332   0.545   −0.266     0.031   0.180   −5.737   0.036   0.527
  Lean mass (kg)                   −2.926           0.734   0.807   −32.049    0.057   0.152   −0.053   0.033   0.716
  Lean mass index (kg/m^2^)        −2.532           0.564   0.502   −8.966     0.123   0.092   −0.435   0.043   0.365
  Fat mass (kg)                    23.375           0.047   0.150   20.077     0.032   0.212   0.132    0.061   0.148
  Fat mass (%)                     15.583           0.286   0.298   29.174     0.079   0.044   0.116    0.049   0.261
  Fat mass index (kg/m^2^)         6.054            0.053   0.313   7.752      0.032   0.196   0.254    0.046   0.306
  Visceral adipose tissue (g)      148.816          0.217   0.827   −342.253   0.011   0.651   0.000    0.031   0.824

The analyses were controlled for: Sex (Model 1); age (Model 2); both sex and age (Model 3). β---unstandardized regression coefficient; R^2^, and *p* value were obtained from the multiple linear regression analyses. Bold values are values that are significant (*p* \< 0.05).

medicina-54-00091-t005_Table 5

###### 

Association of wake after sleep onset with body composition parameters.

                                   All (*n* = 74)                                                              
  -------------------------------- ---------------- ------- ------- -------- ------- ------- --------- ------- -------
  Body mass index (kg/m^2^)        −0.010           0.184   0.502   −0.006   0.025   0.739   −0.634    0.011   0.528
  Waist-Hip ratio                  −7.338           0.386   0.807   4.170    0.020   0.912   −13.219   0.006   0.791
  Bone mineral content (g)         −0.414           0.637   0.737   0.509    0.003   0.803   −0.004    0.007   0.771
  Bone mineral density (g/cm^2^)   0.000            0.329   0.745   0.000    0.010   0.546   14.698    0.007   0.714
  Lean mass (kg)                   0.004            0.734   0.897   0.031    0.034   0.551   0.186     0.007   0.772
  Lean mass index (kg/m^2^)        0.005            0.563   0.580   0.011    0.096   0.365   1.764     0.016   0.406
  Fat mass (kg)                    −0.055           0.049   0.136   −0.053   0.040   0.151   −0.604    0.039   0.132
  Fat mass (%)                     −0.034           0.285   0.321   −0.047   0.023   0.224   −0.506    0.023   0.269
  Fat mass index (kg/m^2^)         −0.014           0.054   0.307   −0.016   0.027   0.253   −1.152    0.022   0.294
  Visceral adipose tissue (g)      −0.510           0.218   0.741   −0.107   0.008   0.951   −0.003    0.007   0.735

The analyses were controlled for: Sex (Model 1); age (Model 2); both sex and age (Model 3). β---unstandardized regression coefficient; R2, and *p* value were obtained from the multiple linear regression analyses.
